| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.085 | 0.009 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.68 | 0.01 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.075 | 0.01 |